Page last updated: 2024-10-28

phenelzine and Alveolar Bone Atrophy

phenelzine has been researched along with Alveolar Bone Atrophy in 1 studies

Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekuni, D1
Firth, JD1
Nayer, T1
Tomofuji, T1
Sanbe, T1
Irie, K1
Yamamoto, T1
Oka, T1
Liu, Z1
Vielkind, J1
Putnins, EE1

Other Studies

1 other study available for phenelzine and Alveolar Bone Atrophy

ArticleYear
Lipopolysaccharide-induced epithelial monoamine oxidase mediates alveolar bone loss in a rat chronic wound model.
    The American journal of pathology, 2009, Volume: 175, Issue:4

    Topics: Alveolar Bone Loss; Animals; Chronic Disease; Disease Models, Animal; Epithelial Cells; Hydrogen Per

2009